retatrutide phase 2 diabetes weight loss 2024 with as compared to currently licenced obesity Lilly's triple agonist achieves 16.8%

Before starting any weight loss medication, a thorough medical assessment is essential

However, it can be life-saving if the patient is hypoglycemic

Increasing global obesity prevalence heightens the need for effective pharmacological interventions that can address weight gain, metabolic dysfunction and the progression of obesity-related chronic diseases

The danger of muscle loss during weight loss

You get your medication from your GP, a pharmacy, or another online provider, then use WeightWatchers programme for behavioural support alongside your treatment

Patient Advocate Foundation (PAF) Patient Advocate Foundation offers financial assistance and grants to patients with chronic illnesses, including support for medication costs related to diabetes and other long-term conditions